Novel 1,2-diarylcyclobutenes: Selective and orally active cox-2 inhibitors
- 19 November 1996
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 6 (22) , 2677-2682
- https://doi.org/10.1016/s0960-894x(96)00501-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): Rationale for selective inhibition and progress to dateMedicinal Research Reviews, 1996
- Synthesis and biological evaluation of 2,3-diarylthiophenes as selective cox-2 inhibitors. part II: Replacing the heterocycleBioorganic & Medicinal Chemistry Letters, 1996
- Diaryl indenes and benzofurans: Novel classes of potent and selective cyclooxygenase-2 inhibitorsBioorganic & Medicinal Chemistry Letters, 1995
- Selective cyclooxygenase inhibitors: Novel 4-spiro 1,2-diarylcyclopentenes are potent and orally active cox-2 inhibitorsBioorganic & Medicinal Chemistry Letters, 1995
- Chapter 19. Selective Cyclooxygenase InhibitorsPublished by Elsevier ,1995
- Selective Cyclooxygenase Inhibitors: Novel 1,2-Diarylcyclopentenes Are Potent and Orally Active COX-2 InhibitorsJournal of Medicinal Chemistry, 1994
- Platelet activation and arterial thrombosisThe Lancet, 1994
- Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1992
- Renal Syndromes Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1984
- Organic chemistry of low-valent titaniumAccounts of Chemical Research, 1974